Aspen Aerogels (: ASPN) reported Q3 EPS of ($0.11), $0.05 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $31.5 million versus the consensus estimate of $30.85 million.

Adjusted EBITDA for the third quarter of 2015 was $1.7 million, compared to $1.2 million in the third quarter of 2014.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.